Sphingolipids in anticancer therapy

被引:32
作者
Padrón, JM
机构
[1] Hosp Univ NS Candelaria, Inst Canario Invest Canc, Unidad Invest, Santa Cruz de Tenerife 38010, Spain
[2] Red Temat Invest Cooperat Ctr Canc, Inst Canario Invest Canc, Santa Cruz de Tenerife 38010, Spain
[3] Univ La Laguna, Inst Univ Bioorgan Antonio Gonzalez, E-38206 San Cristobal la Laguna, Spain
关键词
sphingolipid analogs; sphingosine; ceramide; apoptosis; signal transduction; anticancer drugs; structure-activity relationships; drug design;
D O I
10.2174/092986706776055553
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingolipids constitute a broad class of compounds with many biological functions. The sphingolipid metabolites ceramide and sphingosine are potent apoptosis inducers and produce cell cycle arrest, whereas sphingosine-1-phosphate promotes cellular growth and differentiation. Herein, the effects of sphingolipids and their analogs on diverse signaling pathways implicated in the apoptotic process are highlighted. The relatively simple chemical structure of these compounds has led to several strategies for their total synthesis. Those methods have contributed to the development and biological study of several analogs that present diverse degree of modification from the original structure. This article catalogues many of the recently developed synthetic analogs that act on diverse aspects of sphingolipid metabolism. A description of known enzyme inhibitors of the sphigolipids pathway is also given. Finally, diverse new sphingolipid-like antitumor agents isolated from marine sources are presented. This contribution opens the way for future development of new sphingolipid analogs that might be useful in cancer chemotherapy.
引用
收藏
页码:755 / 770
页数:16
相关论文
共 168 条
  • [1] Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA
    Abousalham, A
    Liossis, C
    OBrien, L
    Brindley, DN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1069 - 1075
  • [2] Acena J. L., 2004, U.S. Patent, Patent No. [0048834A1, 0048834, 048834A1, 048834]
  • [3] Cytotoxic sphingosine 4-sulfates from the sponge Spirastrella abata
    Alam, N
    Wang, WH
    Hong, JK
    Lee, CO
    Im, KS
    Jung, JH
    [J]. JOURNAL OF NATURAL PRODUCTS, 2002, 65 (06): : 944 - 945
  • [4] PENAZETIDINE-A, AN ALKALOID INHIBITOR OF PROTEIN-KINASE-C
    ALVI, KA
    JASPARS, M
    CREWS, P
    STRULOVICI, B
    OTO, E
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (20) : 2447 - 2450
  • [5] Ceramide signalling and the immune response
    Ballou, LR
    Laulederkind, SJF
    Rosloniec, EF
    Raghow, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1301 (03): : 273 - 287
  • [6] The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
    Bandhuvula, P
    Tam, YY
    Oskouian, B
    Saba, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (40) : 33697 - 33700
  • [7] Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta
    Berra, E
    DiazMeco, MT
    Lozano, J
    Frutos, S
    Municio, MM
    Sanchez, P
    Sanz, L
    Moscat, J
    [J]. EMBO JOURNAL, 1995, 14 (24) : 6157 - 6163
  • [8] Total synthesis of cytotoxic anhydrophytosphingosine pachastrissamine (Jaspine B)
    Bhaket, P
    Morris, K
    Stauffer, CS
    Datta, A
    [J]. ORGANIC LETTERS, 2005, 7 (05) : 875 - 876
  • [9] Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants
    Bieberich, E
    Silva, J
    Wang, GH
    Krishnamurthy, K
    Condie, BG
    [J]. JOURNAL OF CELL BIOLOGY, 2004, 167 (04) : 723 - 734
  • [10] Synthesis and characterization of novel ceramide analogs for induction of apoptosis in human cancer cells
    Bieberich, E
    Hu, B
    Silva, J
    MacKinnon, S
    Yu, RK
    Fillmore, H
    Broaddus, WC
    Ottenbrite, RM
    [J]. CANCER LETTERS, 2002, 181 (01) : 55 - 64